Literature DB >> 28912620

Hormonal contraception and the development of autoimmunity: A review of the literature.

William V Williams1,2.   

Abstract

Estrogens and progestins are known to have profound effects on the immune system and may modulate the susceptibility to autoimmune diseases. A comprehensive literature search was carried out using PubMed for any of 153 autoimmune disease terms and the terms contraception, contraceptive, or their chemical components with limits of Humans + Title or Abstract. Over 1,800 titles were returned and scanned, 352 papers retrieved and reviewed in depth and an additional 70 papers retrieved from the bibliographies. Based on this review, substantial evidence exists linking the use of combined oral contraceptives to a lower incidence of hyperthyroidism, an increase in multiple sclerosis, ulcerative colitis, Crohn's disease, Systemic Lupus Erythematosus, and interstitial cystitis. Progesterone only contraceptives are linked to progesterone dermatitis and in one large developing world concurrent cohort study are associated with increases in arthropathies and related disorders, eczema and contact dermatitis, pruritis and related conditions, alopecia, acne, and urticaria. Hormonal contraceptives modulate the immune system and may influence the susceptibility to autoimmune diseases with significant increases in risk for several autoimmune diseases.
SUMMARY: Hormonal contraceptives (HCs), such as the "pill," Norplant, and vaginal rings, are very potent hormones that have effects on the immune system, which is made up of white blood cells and lymph nodes and normally defends the body against invading bacteria, viruses and parasites. This review looked at the association of HC use to the development of autoimmune diseases, where the immune system turns against the body and causes damage to organs. There is good evidence that HC use is associated with an increased risk of several serious autoimmune diseases such as Crohn's disease (which causes inflammation of the bowels), Lupus (which causes inflammation in many organs), and interstitial cystitis (which causes inflammation in the bladder). Several other rarer autoimmune diseases are also linked to HC use. People contemplating the use of HCs should be informed of these risks.

Entities:  

Keywords:  Autoimmune disease; Autoimmunity; Hormonal contraceptives; Oral contraceptive pills; Progesterone only contraceptives

Year:  2017        PMID: 28912620      PMCID: PMC5592309          DOI: 10.1080/00243639.2017.1360065

Source DB:  PubMed          Journal:  Linacre Q        ISSN: 0024-3639


  139 in total

1.  ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions.

Authors: 
Journal:  Obstet Gynecol       Date:  2006-06       Impact factor: 7.661

Review 2.  Hormonal modulation of the immune system - A spotlight on the role of progestogens.

Authors:  Irene J Tan; Elena Peeva; Gisele Zandman-Goddard
Journal:  Autoimmun Rev       Date:  2015-02-16       Impact factor: 9.754

Review 3.  The epidemiology of multiple sclerosis: insights to disease pathogenesis.

Authors:  Douglas S Goodin
Journal:  Handb Clin Neurol       Date:  2014

4.  Pregnancy does not cause systemic lupus erythematosus to worsen.

Authors:  M D Lockshin
Journal:  Arthritis Rheum       Date:  1989-06

5.  Tobacco smoking and excess mortality in multiple sclerosis: a cohort study.

Authors:  Ali Manouchehrinia; Mikail Weston; Christopher R Tench; John Britton; Cris S Constantinescu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-02-25       Impact factor: 10.154

6.  Oral contraceptive pill use and abnormal menstrual cycles in women with severe condylar resorption: a case for low serum 17beta-estradiol as a major factor in progressive condylar resorption.

Authors:  Michael J Gunson; G William Arnett; Bent Formby; Charles Falzone; Ruchi Mathur; Carolyn Alexander
Journal:  Am J Orthod Dentofacial Orthop       Date:  2009-12       Impact factor: 2.650

7.  Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women's Health Study.

Authors:  Yvette C Cozier; Jeffrey S Berman; Julie R Palmer; Deborah A Boggs; Lauren A Wise; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2012-09-11       Impact factor: 4.897

8.  Natural history of severe ulcerative colitis in a community-based health plan.

Authors:  James Allison; Lisa J Herrinton; Liyan Liu; Jenny Yu; James Lowder
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09       Impact factor: 11.382

9.  Benefits of progestin contraception in non-allergic angioedema.

Authors:  C Saule; I Boccon-Gibod; O Fain; G Kanny; G Plu-Bureau; L Martin; D Launay; L Bouillet; A Gompel
Journal:  Clin Exp Allergy       Date:  2013-04       Impact factor: 5.018

10.  Resolution of autoimmune progesterone dermatitis after treatment with oral contraceptives.

Authors:  John B Fournier
Journal:  JAAD Case Rep       Date:  2015-08-25
View more
  14 in total

Review 1.  Hormonal Contraceptives and Dermatology.

Authors:  Natalie M Williams; Michael Randolph; Ali Rajabi-Estarabadi; Jonette Keri; Antonella Tosti
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

2.  Hormonally Active Contraceptives, Part II: Sociological, Environmental, and Economic Impact.

Authors:  William V Williams; Joel Brind; Laura Haynes; Michael D Manhart; Hanna Klaus; Angela Lanfranchi; Gerard Migeon; Michael Gaskins; Elvis I Šeman; Lester Ruppersberger; Kathleen M Raviele
Journal:  Linacre Q       Date:  2021-04-21

3.  Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study.

Authors:  Kristin E Burke; Ashwin N Ananthakrishnan; Paul Lochhead; Po-Hong Liu; Ola Olen; Jonas F Ludvigsson; James M Richter; Shelley S Tworoger; Andrew T Chan; Hamed Khalili
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

4.  Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged.

Authors:  William V Williams; Joel Brind; Laura Haynes; Michael D Manhart; Hanna Klaus; Angela Lanfranchi; Gerard Migeon; Mike Gaskins; Elvis I Seman; Lester Ruppersberger; Kathleen M Raviele
Journal:  Linacre Q       Date:  2021-01-27

5.  Interstitial Cystitis or Painful Bladder Syndrome in a Premenopausal Female Precipitated by Oral Combined Contraceptives.

Authors:  Anna Thompson; Ashley E Siegel; Zachery Thompson; John M Tramont
Journal:  Cureus       Date:  2020-05-29

6.  Genomic imprinting analyses identify maternal effects as a cause of phenotypic variability in type 1 diabetes and rheumatoid arthritis.

Authors:  Inga Blunk; Hauke Thomsen; Norbert Reinsch; Manfred Mayer; Asta Försti; Jan Sundquist; Kristina Sundquist; Kari Hemminki
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

7.  Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study.

Authors:  Dorte Glintborg; Katrine Hass Rubin; Mads Nybo; Bo Abrahamsen; Marianne Andersen
Journal:  Endocr Connect       Date:  2019-10-01       Impact factor: 3.335

8.  Birth control pills and risk of hypothyroidism: a cross-sectional study of the National Health and Nutrition Examination Survey, 2007-2012.

Authors:  Yuxuan Qiu; Yuanyuan Hu; Zhichao Xing; Qingyu Fu; Jingqiang Zhu; Anping Su
Journal:  BMJ Open       Date:  2021-06-23       Impact factor: 2.692

Review 9.  Sex Hormones in Acquired Immunity and Autoimmune Disease.

Authors:  Vaishali R Moulton
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

10.  Diffuse Alveolar Hemorrhage after Receiving Oral Levonorgerstrel for Emergency Contraception: A Case Report.

Authors:  Athina Georgopoulou; Efthymia Papadopoulou; Marianna Moyseos; Sofia-Chrysovalantou Zagalioti; Christos Hatzis; Dimitrios Karanasios; Stavros Tryfon
Journal:  Clin Med Insights Case Rep       Date:  2021-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.